Last Update: 12-31-1969

Number of Stocks:
Number of New Stocks:

Total Value: $0 Mil
Q/Q Turnover: %

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:


  • How China Lost an Entire Spain in 17 Days

    Concerned about a tumbling equity market, PBOC moved to cut both interest rates and the reserve requirement ratio for banks over the weekend. However, increasingly wary of a market bubble in China, investors still sent Shanghai Composite spiraling down another 3.3% on Monday after the dramatic 7.4% plunge last Friday despite the support from the central bank.



  • Steve Romick: Waiting for Another Bite at the Apple

    With little margin of safety available in today's market, the Gold-rated FPA Crescent manager is waiting for better opportunities.


  • Why I Am Buying Gilead Sciences

    This is the final stock I purchased with the cash that was sent my way when Reynolds American, Inc. (RAI) acquired Lorillard Inc., upon which I received some stock in the former company and cash after relinquishing my holdings in the latter company.

    I will note that this is a rather speculative play, in my view. This company doesn’t have the lengthy dividend growth history that I almost exclusively look for – the company actually just recently announced its first-ever dividend. But I think the valuation and promise are compelling enough to initiate a small position here and see where things go. I’m excited.


  • Four stocks with growing EPS near their 52 weeks low

    With these articles, thanks to GuruFocus All-In-One Screener, I want to highlight stocks that got a strong price correction, and that are trading near their 52 weeks low but that can be good for investors, since they have growing earnings over the last years.

    HCP Inc (HCP)


  • Book Review: The Magic Of Reality

    The world of science has led to discoveries more wondrous than anything we can make up, and Richard Dawkins takes us through a number of examples in The Magic of Reality. This was an excellent book from which I learned a heck of a lot.

    In general my track record with science books is rather weak. I manage to follow the author to a certain point, after which I get a little lost. My confusion leads to my enjoyment level dropping, which makes it hard to stay motivated to keep following along. I have experienced this with the biographies of Einstein, Farraday, and in books by Stephen Hawking. I had no such problem with this book. The concepts are explained very clearly, so that even a dummy like me could understand them.

    Of course, the trade-off is that some things were discussed that were rather basic such that I already knew them. One example is how evolution works, which, except for the most religious among you, is probably understood by most adults very well.


  • Greece versus Germany - Which is the Villain?

    Fun, Fun, Fun … ‘til her daddy takes the T-bird away

    The Beach Boys decode international affairs for us


  • Oracle Is A Great Deal For Value Investors

    Oracle Corporation (ORCL) has shown some earnings growth over the last few years and has a healthy dividend, factors which may garner some attention from prospective investors; however, Benjamin Graham, the father of value investing, taught that the most important aspect to consider is whether the company is trading at a discount relative to its intrinsic value. It is through a thorough fundamental analysis that the investor is able to make a determination about a potential investment's merits.

    The model is inspired by the teachings of Benjamin Graham and considers numerous metrics intended to help the investor reduce risk levels. The first part of the analysis is to determine whether the company is suitable for the very conservative defensive investor or the less conservative enterprising investor, who is willing to spend a greater amount of time conducting further research.


  • Peter Lynch Portfolio - Trade Alerts

    High Tech with Low-Risk

    TSM: Semi-Tough

    Our Peter Lynch Portfolio 29 bought shares and sold two put contracts on what is a new name for us yesterday afternoon.

    Taiwan Semiconductor (TSM) opened the world’s first dedicated contract semiconductor foundry in 1987. They remain the global leader in the field with projected 2015 sales of more than $27 billion.

    Fabless customers (those without their own manufacturing facilities) accounted for about 85% of last year’s revenue. Integrated device makers booked up the rest of TSM’s capacity in 2014. TSM is a low-risk play on the overall volume of technology wafer production.

    Earnings per share grew steadily, from $0.54 in recession ravaged 2009, to $1.68 in 2014. Q1 numbers were up more than 54%, at $0.48 versus $0.31. Full year estimates now center on $1.85, an all-time best.

    TSM’s shares paralleled the rising profits, moving from below $7 to as high as $25.77. TSM went Monday ex-dividend on Monday for a payment of about $0.73. That, combined with the Greece-related market sell-off, drove TSM down to under $23 again.

    The company is financially strong. As of Mar. 31, 2015, TSM’s long-term debt was under $6.8 billion while corporate cash totaled above $16.5 billion.

    Monday's sell-off allowed for a great entry point. The stock’s impressive six-year rise has been outdistanced by the improved fundamentals. TSM closed on Jun. 26, 2015, at $22.38 per share.

    Value Line noted that the company’s 10-year median multiple is14x. Its post-recession average was 13.7x. TSM’s current year P/E now sits near 12.1x its 2015 projection and only 11.5x next year’s estimate. Those are among the cheapest valuations for TSM during the past six years. TSM appears to be a classic GARP (Growth At a Reasonable Price) investment.

    2015’s almost 73-cent dividend was the highest yet. Note that TSM pays the entire amount, once each year. Payouts are subject to 15% foreign tax withholding. This year’s payment equated to a very nice 3.26% on a pre-tax basis. Non-sheltered accounts can recoup foreign withholding via a tax credit.

    Simply returning to a normalized valuiation implies Taiwan Semi could reach at least $27 - $28 over the next 12 to 18 months. That implies upside of around 22% on top on the normal dividend that should be paid around late June in 2016.

    Research outfit Standard & Poors confirms that idea. They see $27 as a 12-month goal and call 'fair value' as a bit higher than that.

    We bought 134 shares at $22.40, using $3001.60 from our cash reserve fund. Our cash balance is now down to $11,700.47 from an origianl $100,000 stake.

    At 12:10 PM on Monday our Peter Lynch Puit writing Portfolio was able to collect $1.90 per share in option premium by selling two contracts of TSM's Jan. 20, 2017, $20 puts.

    Break-even on that short sale dropped the ‘if exercised’ price all the way down to $18.10 ($20 strike price - $1.90 put premium). TSM has not changed hands for that low a price since March of 2014.

    Maximum profit would be keeping 100% of the $380 premium received. The worst case scenario would be forced purchase of 200 additional TSM shares at very close to the firm's 15-month exact low.

    Taiwan Semi is appealing as a relatively low-beta way to play tech. It appears less risky than the better-known semiconductor names it does business with.

    Disclosure: Long TSM shares, short TSM Jan. 2017, $20 puts in my personal accounts


  • Here's Why Cisco Should Consider Buying Ubiquiti

    Ubiquiti Networks (UBNT) has been pretty volatile over the last few weeks. Despite the company not reporting good quarterly numbers, the stock is up over 10% this year. There are several factors that can push the stock much higher than present levels. One such reason is a potential buyout by Cisco (CSCO). Cisco has been pretty active on the acquisition front over the past few years and the company even sold $8 billion worth of bonds last year. Needless to say, Cisco has enough money to buyout Ubiquiti. Ubiquiti can help Cisco overcome several weak points. Let’s take a look at the reasons why I think Ubiquiti can be a potential buyout target for Cisco.

    Wireless Internet Service Provider Industry


  • Reasons to Bet On Darden Restaurants

    Darden Restaurants, Inc. (DRI) stock is trading near its 52-week high of $73.40. Although the stock price is relatively expensive to the rest of the industry, in my opinion, it is a "buy" at this current price level.



  • Why I Still Consider Kroger as a Buy Recommendation

    In this article, let's take a look at the supermarket operator Kroger Co (KR) and try to explain if this is an appealing investment opportunity or not, when shares of the company are trading nearly its 52-week high. Shares of the firm closed yesterday at $73.11, amassing a year-to-date return of 13.6%, which I consider attractive when compared to a market benchmark such as the SPDR S&P 500 ETF (SPY). Further, the past September I wrote an article recommending the stock, and I think it has done pretty good, with a 42% return in the period.

    Company’s Competitive Environment


  • Weekly 3-Year Low Highlights: XOM, SO, HCP, KT, CBL

    According to GuruFocus list of 3-year lows, Exxon Mobil Corporation, Southern Co, HCP Inc, KT Corporation, and CBL & Associates Properties Inc. have all reached their 3-year lows.

    Exxon Mobil Corporation (XOM) Reached $83.86


  • Casino Industry Still on the Growth Path

    As more persons get involve in casino betting, the industry seems to be getting bigger each year. In fact, some countries depend on casino gambling to help their ailing economy.

    So far, the global casino business is already worth in the billions of dollars. In fact, the US casino industry since 2014 is well worth in the excess of $240 billion and by the end of 2015, experts are predicting growth to reach over $357 billion. In 2013, the industry had 1.7 million workers reporting to work on a daily basis inside the casino houses located in the US. On a whole, the US government is raking in a whopping $8 billion in local taxes and this amount is expected to climb as the industry continues to show signs of growth in the face of economic adversities.


  • Andreas Halvorsen Increases Stake in Esperion Therapeutics

    Andreas Halvorsen (Trades, Portfolio)’s hedge fund Viking Global Investors increased its stake in pharmaceutical company Esperion Therapeutics (ESPR) by 875.1% on June 18, GuruFocus Real Time Picks reported Monday.

    Founded in 2008, Esperion makes treatments for heart disease patients who experience intolerable side effects from existing drugs. Halvorsen holds 1,335,101 shares of the company, a 5.9% stake, after the increase. He began the position in the first quarter with 136,919 shares.


  • European Metals Corporate Update

  • Perlite Canada Inc. Announces Its Results for the Second Quarter of 2015

  • Marifil Mines Ltd Annouces Grant of Incentive Stock Options

  • CaNickel Reports of Voting Results of Annual Meeting

  • Jaguar Resources Inc. Provides Update on Bannock Creek Exploration Well, and Announces a 4 Well Drilling Program and an Option for 6 More Wells

  • Cynapsus Therapeutics Enrolls First Patient in Pivotal Phase 3 Efficacy Study

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)